231 related articles for article (PubMed ID: 35069971)
1. Identification of Aging-Related Genes Associated with Prognostic Value and Immune Microenvironment Characteristics in Diffuse Large B-Cell Lymphoma.
Luo C; Nie H; Yu L
Oxid Med Cell Longev; 2022; 2022():3334522. PubMed ID: 35069971
[TBL] [Abstract][Full Text] [Related]
2. CCL8 as a promising prognostic factor in diffuse large B-cell lymphoma
Lou X; Zhao K; Xu J; Shuai L; Niu H; Cao Z; Wang J; Zhang Y
Front Immunol; 2022; 13():950213. PubMed ID: 36072582
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analysis of the prognostic implication and immune infiltration of CISD2 in diffuse large B-cell lymphoma.
Zhang C; Lin Q; Li C; Qiu Y; Chen J; Zhu X
Front Immunol; 2023; 14():1277695. PubMed ID: 38155967
[TBL] [Abstract][Full Text] [Related]
4. Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature.
He J; Chen Z; Xue Q; Sun P; Wang Y; Zhu C; Shi W
J Transl Med; 2022 Apr; 20(1):186. PubMed ID: 35468826
[TBL] [Abstract][Full Text] [Related]
5. Analysis of endoplasmic reticulum stress-related gene signature for the prognosis and pattern in diffuse large B cell lymphoma.
Zhang C; Lin Q; Li C; Chen Z; Deng M; Weng H; Zhu X
Sci Rep; 2023 Aug; 13(1):13894. PubMed ID: 37626099
[TBL] [Abstract][Full Text] [Related]
6. Identifying
Xiang X; Gao LM; Zhang Y; Zhu Q; Zhao S; Liu W; Ye Y; Tang Y; Zhang W
PeerJ; 2023; 11():e16618. PubMed ID: 38099311
[TBL] [Abstract][Full Text] [Related]
7. Prediction significance of autophagy-related genes in survival probability and drug resistance in diffuse large B-cell lymphoma.
Xiong D; Wei X; Huang W; Zheng J; Feng R
Aging (Albany NY); 2024 Jan; 16(2):1049-1076. PubMed ID: 38240686
[TBL] [Abstract][Full Text] [Related]
8. A novel NET-related gene signature for predicting DLBCL prognosis.
Shi H; Pan Y; Xiang G; Wang M; Huang Y; He L; Wang J; Fang Q; Li L; Liu Z
J Transl Med; 2023 Sep; 21(1):630. PubMed ID: 37716978
[TBL] [Abstract][Full Text] [Related]
9. An Immune-Related Prognostic Classifier Is Associated with Diffuse Large B Cell Lymphoma Microenvironment.
Liang XJ; Fu RY; Wang HN; Yang J; Yao N; Liu XD; Wang L
J Immunol Res; 2021; 2021():5564568. PubMed ID: 34212052
[TBL] [Abstract][Full Text] [Related]
10. Ferroptosis-related STEAP3 acts as predictor and regulator in diffuse large B cell lymphoma through immune infiltration.
Chen X; Hu S; Han Y; Cai Y; Lu T; Hu X; Chu Y; Zhou X; Wang X
Clin Exp Med; 2023 Oct; 23(6):2601-2617. PubMed ID: 36682001
[TBL] [Abstract][Full Text] [Related]
11. Ferroptosis Markers Predict the Survival, Immune Infiltration, and Ibrutinib Resistance of Diffuse Large B cell Lymphoma.
Weng J; Chen L; Liu H; Yang XP; Huang L
Inflammation; 2022 Jun; 45(3):1146-1161. PubMed ID: 35064379
[TBL] [Abstract][Full Text] [Related]
12. A novel lipid metabolism-based risk model associated with immunosuppressive mechanisms in diffuse large B-cell lymphoma.
Zhang Z; Zhao C; Yang S; Lu W; Shi J
Lipids Health Dis; 2024 Jan; 23(1):20. PubMed ID: 38254162
[TBL] [Abstract][Full Text] [Related]
13. Expression of N
Xie Z; Li M; Hong H; Xu Q; He Z; Peng Z
Bioengineered; 2021 Dec; 12(1):6115-6133. PubMed ID: 34482808
[TBL] [Abstract][Full Text] [Related]
14. Identification and Validation of a Prognostic Prediction Model in Diffuse Large B-Cell Lymphoma.
Yan J; Yuan W; Zhang J; Li L; Zhang L; Zhang X; Zhang M
Front Endocrinol (Lausanne); 2022; 13():846357. PubMed ID: 35498426
[TBL] [Abstract][Full Text] [Related]
15. Identification and Validation of a DNA Damage Repair-Related Signature for Diffuse Large B-Cell Lymphoma.
Li Y; Liu X; Chang Y; Fan B; Shangguan C; Chen H; Zhang L
Biomed Res Int; 2022; 2022():2645090. PubMed ID: 36281462
[TBL] [Abstract][Full Text] [Related]
16. Immune microenvironment-related gene mapping predicts immunochemotherapy response and prognosis in diffuse large B-cell lymphoma.
Chen W; Liang W; He Y; Liu C; Chen H; Lv P; Yao Y; Zhou H
Med Oncol; 2022 Jan; 39(4):44. PubMed ID: 35092504
[TBL] [Abstract][Full Text] [Related]
17. International Prognostic Index-Based Immune Prognostic Model for Diffuse Large B-Cell Lymphoma.
Mu S; Shi D; Ai L; Fan F; Peng F; Sun C; Hu Y
Front Immunol; 2021; 12():732006. PubMed ID: 34745101
[TBL] [Abstract][Full Text] [Related]
18. Identification and Development of a 4-Gene Ferroptosis Signature Predicting Overall Survival for Diffuse Large B-Cell Lymphoma.
Wu H; Zhang J; Fu L; Wu R; Gu Z; Yin C; He K
Technol Cancer Res Treat; 2023; 22():15330338221147772. PubMed ID: 36762399
[No Abstract] [Full Text] [Related]
19. Whole Transcriptome Data Analysis Reveals Prognostic Signature Genes for Overall Survival Prediction in Diffuse Large B Cell Lymphoma.
Pan M; Yang P; Wang F; Luo X; Li B; Ding Y; Lu H; Dong Y; Zhang W; Xiu B; Liang A
Front Genet; 2021; 12():648800. PubMed ID: 34178023
[TBL] [Abstract][Full Text] [Related]
20. Machine-learning-based classification of diffuse large B-cell lymphoma patients by a 7-mRNA signature enriched with immune infiltration and cell cycle.
Zhuang X; Liu B; Long J; Wang H; Yu J; Ji X; Li J; Zhu N; Li L; Chen Y; Liu Z; Zhao S
Clin Transl Oncol; 2024 Apr; 26(4):936-950. PubMed ID: 37783922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
